Sprout CEO on FDA’s approval of women’s sex drug Addyi

August 19, 2015, 8:10 AM|The FDA is giving the green light to flibanserin, the first prescription medication for women’s sexual dysfunction. First on “CBS This Morning,” Sprout Pharmaceuticals CEO Cindy Whitehead joins the show to discuss the pink pill that her company will market under the brand name “Addyi.”